Samsara BioCapital

Develops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases

Develops next-generation bispecific ADCs for cancer treatment

Develops orally delivered, small molecule-based therapies for obesity and other metabolic disorders

Develops novel bispecific antibodies for targeted degradation of extracellular proteins in oncolo...

Develops medicines targeting historically undruggable protein targets in cancer